Your browser doesn't support javascript.
High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh, Kirby; van der Does, Yuri; Engelen, Susanna; de Jong, Evelien; Ramakers, Christian; Gommers, Diederik; van Gorp, Eric; Endeman, Henrik.
  • Tong-Minh K; Department of Emergency Medicine, Erasmus University Medical Center, Nc-017k, Postbus 2040, 3000 CA, Rotterdam, The Netherlands. k.tong-minh@erasmusmc.nl.
  • van der Does Y; Department of Emergency Medicine, Erasmus University Medical Center, Nc-017k, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • Engelen S; Department of Emergency Medicine, Erasmus University Medical Center, Nc-017k, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • de Jong E; Department of Intensive Care, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands.
  • Ramakers C; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Gommers D; Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Gorp E; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Endeman H; Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
BMC Infect Dis ; 22(1): 165, 2022 Feb 21.
Article in English | MEDLINE | ID: covidwho-1700326
ABSTRACT

BACKGROUND:

Patients with a severe COVID-19 infection often require admission at an intensive care unit (ICU) when they develop acute respiratory distress syndrome (ARDS). Hyperinflammation plays an important role in the development of ARDS in COVID-19. Procalcitonin (PCT) is a biomarker which may be a predictor of hyperinflammation. When patients with COVID-19 are in the emergency department (ED), elevated PCT levels could be associated with severe COVID-19 infections. The goal of this study is to investigate the association between PCT levels and severe COVID-19 infections in the ED.

METHODS:

This was a retrospective cohort study including patients with a confirmed COVID-19 infection who visited the ED of Erasmus Medical Center in Rotterdam, the Netherlands, between March and December 2020. The primary outcome was a severe COVID-19 infection, which was defined as patients who required ICU admission, all cause in-hospital mortality and mortality within 30 days after hospital discharge. PCT levels were measured during the ED visit. We used logistic regression to calculate the odds ratio (OR) with 95% confidence interval (95% CI) and corresponding area under the curve (AUC) of PCT on a severe COVID-19 infection, adjusting for bacterial coinfections, age, sex, comorbidities, C-reactive protein (CRP) and D-dimer.

RESULTS:

A total of 332 patients were included in the final analysis of this study, of which 105 patients reached the composite outcome of a severe COVID-19 infection. PCT showed an unadjusted OR of 4.19 (95%CI 2.52-7.69) on a severe COVID-19 infection with an AUC of 0.82 (95% CI 0.76-0.87). Corrected for bacterial coinfection, the OR of PCT was 4.05 (95% CI 2.45-7.41). Adjusted for sex, bacterial coinfection, age any comorbidity, CRP and D-dimer, elevated PCT levels were still significantly associated with a severe COVID-19 infection with an adjusted OR of 2.11 (95% CI 1.36-3.61). The AUC of this multivariable model was 0.85 (95%CI 0.81-0.90).

CONCLUSION:

High PCT levels are associated with high rates of severe COVID-19 infections in patients with a COVID-19 infection in the ED. The routine measurement of PCT in patients with a COVID-19 infection in the ED may assist physicians in the clinical decision making process regarding ICU disposition.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Procalcitonin / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07144-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Procalcitonin / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07144-5